Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Journal of Thoracic Disease|September 4, 2018
Viral infection in community acquired pneumonia patients with fever: a prospective observational studyRu-Jia Tao, Xiao-Li Luo, Wen Xu, et al.
The Lancet. Respiratory Medicine|March 28, 2025
Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trialNan-Shan Zhong, Rong Qiu, Jie Cao, et al.
Annals of the American Thoracic Society|November 14, 2023
Quality-of-Life Bronchiectasis Respiratory Symptom Scale Predicts the Risk of Exacerbations in Adults with Bronchiectasis: A Prospective Observational StudyYong-Hua Gao, Hui-Zhen Zheng, Hai-Wen Lu, et al.
Ebiomedicine|October 17, 2025
Pre-admission fine particulate matter exposure is associated with invasive pulmonary aspergillosis in patients with severe pneumonia, results from two multicenter cohort studiesHua Zhou, Shupeng Zhu, Yujing Li, et al.
Chest|July 21, 2022
A Double-Blind Randomized Placebo-Controlled Phase 3 Trial of Tobramycin Inhalation Solution in Adults With Bronchiectasis With Pseudomonas aeruginosa InfectionWei-Jie Guan, Jin-Fu Xu, Hong Luo, et al.
Frontiers in Public Health|May 30, 2023
Risk factors associated with indoor transmission during home quarantine of COVID-19 patientsYang Liu, Yan-Hua Chai, Yi-Fan Wu, et al.
Respiratory Research|December 3, 2022
The Establishment of China Bronchiectasis Registry and Research Collaboration (BE-China): Protocol of a prospective multicenter observational studyYong-Hua Gao, Hai-Wen Lu, Bei Mao, et al.
American Journal of Respiratory and Critical Care Medicine|June 25, 2026
The frequent exacerbator phenotype in bronchiectasis revisited: Data from EMBARC registryOriol Sibila, Lidia Perea, Pierre Regis Burgel, et al.
American Journal of Respiratory and Critical Care Medicine|January 17, 2012
Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activationJin-Fu Xu, George R Washko, Kiichi Nakahira, et al.
ERJ Open Research|February 27, 2024
A phase 4 multicentre, 2×2 factorial randomised, double-blind, placebo-controlled trial to investigate the efficacy and safety of tobramycin inhalation solution for Pseudomonas aeruginosa eradication in bronchiectasis: ERASEYong-Hua Gao, Hai-Wen Lu, Hui-Zhen Zheng, et al.
Pageof 14